Please Wait...

Books and Book Sections

Books and Book Sections

2014

Miller CG, Krasnow J, Schwartz LH. Medical Imaging in Clinical Trials. Published by Springer-Verlag London Ltd. 2014.

Hide All Authored Chapters

  • Medical Imaging Modalities
    • H Ahmad, HJ Yu, CG Miller
  • The Metrics and New Imaging Marker Qualification in Medical Imaging Modalities
    • CG Miller
  • Radiation Risks and Dosimetry Assessment
    • D Pearson
  • Imaging Review Charters and Operational Considerations
    • AM Perrone, JA Villetard
  • Defining the Radiological Blinded Read and Adjudication
    • CG Miller
  • Medical Imaging in Drug Development
    • J Krasnow
  • Evaluating and Working with an Imaging Core Laboratory
    • ES Forsthoffer, J Krasnow
  • Monitoring Responses to Therapy in Oncology
    • B Zhao, LH Schwartz
  • Cardiac Imaging in Clinical Trials
    • GP Heyrich, J Krasnow
  • Neuroimaging in Clinical Trials
    • SN Niogi, AJ Tsiouris
  • Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials
    • CG Miller, HJ Yu, Cv Kuijk
  • Body Composition
    • JA Shepherd
  • Optical Coherence Tomography as a Biomarker in Clinical Trials for Ophthalmology and Neurology
    • RC Sergott
  • Nuclear Medicine: An Overview of Imaging Techniques, Clinical Applications and Trials
    • A Mehndiratta, P Anandaraj
  • Contrast Agents in Radiology
    • Hv Tengg-Kobligk, A Mehndiratta
  • Pharmaceutical Industry Perspective Regarding Imaging Techniques
    • J Krasnow

2008

Reid D, Miller CG. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Published by Springer-Verlag London Ltd. 2008.

Hide All Authored Chapters

  • Introduction
    • DM Reid
  • Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis
    • S Dubey, AO Adebajo
  • Development of Biological Therapies for Inflammatory Arthritis
    • N Basu
  • Study Design and End Points for Rheumatoid Arthritis Trials
    • P Geusens, CG Miller
  • Study Design and End Points in Ankylosing Spondylitis Clinical Trials
    • Dvd Heijde
  • Trial Design and Outcomes in Osteoarthritis
    • N Arden
  • Ethical Considerations
    • D Pearson
  • Organization of the Clinical Trial by the Sponsor
    • CG Miller
  • Organization of the Trial attheInvestigator Site
    • J Shotton, DM Reid
  • Role of the Imaging Core Laboratory in Rheumatoid Arthritis and Osteoarthritis Clinical Trials
    • MD Endres, AM Baratelle
  • Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations
    • MR Ehlers, ET Leary
  • Data Analysis and Presentation: Writing a Paper for Publication
    • D Pearson
  • Radiographic Imaging End Points in Rheumatoid Arthritis Trials
    • AM Baratelle, Dvd Heijde
  • Radiography in Clinical Trials Investigating Osteoarthritis
    • Cv Kuijk
  • Use of Quantitative Magnetic Resonance Imaging in the Cross-Sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients
    • JP Raynauld
  • Biochemical Markers as Surrogate End Points of Joint Disease
    • LS Lohmander, DR Eyre
  • Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis
    • SH Ralston
  • Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
    • YB Vergel, D Torgerson

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (52 minutes ago)
ICYMI: Clean Patient Optics: helping #ClinicalResearch teams meet or beat database lock. News https://t.co/pUem5e2cMG
bioclinica (1 hour ago)
Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)

Latest Blogs: